A mini review of nanosuspensions development

References

• Ali HS, York P, Blagden N. (2009). Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm, 375, 107–113.
   PubMed Web of Science ®Google Scholar
• Baert L, van ‘t Klooster G, Dries W, François M, Wouters A, Basstanie E, Iterbeke K, Stappers F, Stevens P, Schueller L, Van Remoortere P, Kraus G, Wigerinck P, Rosier J. (2009). Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. Eur J Pharm Biopharm, 72, 502–508.
   PubMed Web of Science ®Google Scholar
• Ben Zirar S, Astier A, Muchow M, Gibaud S. (2008). Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice. Eur J Pharm Biopharm, 70, 649–656.
   PubMed Web of Science ®Google Scholar
• Borner K, Hartwig H, Leitzke S, Hahn H, Müller RH, Ehlers S. (1999). HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations. Int J Antimicrob Agents, 11, 75–79.
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. (2010). Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm, 396, 210–218.
   PubMed Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, Chang X, Gao J. (2011). Nanonization strategies for poorly water-soluble drugs. Drug Discov Today, 16, 354–360.
   PubMed Web of Science ®Google Scholar
• Chen RH, Tsai ML, Tseng LZ. (2009). Two-stage microfluidization combined with ultrafiltration treatment for chitosan mass production and molecular weight manipulation. Carbohyd Polym, 77, 767–772.
   Web of Science ®Google Scholar
• Chen JF, Wang YH, Guo F, Wang XM, Zheng C. (2000). Synthesis of nanoparticles with novel technology: high-gravity reactive precipitation. Ind Eng Chem Res, 39, 948–954.
   Web of Science ®Google Scholar
• Chen H, Wan J, Wang Y, Mou D, Liu H, Xu H, Yang X. (2008). A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions. Nanotechnology, 19, 375104.
   PubMed Web of Science ®Google Scholar
• Chen JF, Zheng C, Chen GT. (1996). Interaction of macro-and micro-mixing on particle size distribution in reaction precipitation. Chem Eng Sci, 51, 1957–1966.
   Web of Science ®Google Scholar
• Chen JF, Zhou MY, Shao L, Wang YY, Yun J, Chew NY, Chan HK. (2004). Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int J Pharm, 269, 267–274.
   PubMed Web of Science ®Google Scholar
• Chen JF, Zhou XM, Wang YH, Zheng C. (1998). Synthesis of ultrafine calcium carbonate. Chinese Patent No. ZL95105343.4.
   Google Scholar
• Chen JF, Zhou XM, Zheng C. (1995). Ultrafine particle synthesis by high-gravity reactive precipitation. Chinese Patent No. 95105344.2.
   Google Scholar
• Chiang PC, Alsup JW, Lai Y, Hu Y, Heyde BR, Tung D. (2009). Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery. Nanoscale Res Lett, 4, 254–261.
   PubMed Web of Science ®Google Scholar
• Das S, Suresh PK. (2011). Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine, 7, 242–247.
   PubMed Web of Science ®Google Scholar
• Dolenc A, Kristl J, Baumgartner S, Planinsek O. (2009). Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm, 376, 204–212.
   PubMed Web of Science ®Google Scholar
• Fakes MG, Vakkalagadda BJ, Qian F, Desikan S, Gandhi RB, Lai C, Hsieh A, Franchini MK, Toale H, Brown J. (2009). Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. Int J Pharm, 370, 167–174.
   PubMed Web of Science ®Google Scholar
• Feng FF, Zhang DR, Tian KL, Lou HY, Qi XL, Wang YC, Duan CX, Jia LJ, Wang FH, Liu Y, Zhang Q. (2011). Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension. Drug Deliv, 18, 265–271.
   PubMed Web of Science ®Google Scholar
• Fowler R. (1989). Higee-a status report. Chem Eng, 35, 456–473.
   Google Scholar
• Formulation development and evaluation of metronidazole magnetic nanosuspension as a magnetic-targeted and polymeric-controlled drug delivery system. J Magn Magn Mater, 321, 1580–1585.
   Web of Science ®Google Scholar
• Gao Y, Li Z, Sun M, Li H, Guo C, Cui J, Li A, Cao F, Xi Y, Lou H, Zhai G. (2010). Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm, 36, 1225–1234.
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J. (2011). Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int J Pharm, 404, 231–237.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M. (2008a). Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res, 10, 845–862.
   Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M, Duan C, Dai W, Jia L, Zhao W. (2008b). Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int J Pharm, 355, 321–327.
   PubMed Web of Science ®Google Scholar
• Guo K, Guo F, Feng YD, Chen JF, Zheng C, Gardner NC. (2000). Synchronous visual and RTD study on liquid flow inrotating packed-bed contactor. Chem Eng Sci, 55, 1699–1706.
   Web of Science ®Google Scholar
• Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17, 397–404.
   PubMed Web of Science ®Google Scholar
• Hecq J, Deleers M, Fanara D, Vranckx H, Boulanger P, Le Lamer S, Amighi K. (2006). Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. Eur J Pharm Biopharm, 64, 360–368.
   PubMed Web of Science ®Google Scholar
• Jacobs C, Kayser O, Müller RH. (2000). Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm, 196, 161–164.
   PubMed Web of Science ®Google Scholar
• Jacobs C, Kayser O, Müller RH. (2001). Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone. Int J Pharm, 214, 3–7.
   PubMed Web of Science ®Google Scholar
• Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 340, 126–133.
   PubMed Web of Science ®Google Scholar
• Kayser O. (2000). Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. Int J Pharm, 196, 253–256.
   PubMed Web of Science ®Google Scholar
• Kayser O. (2001). A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications. Int J Pharm, 214, 83–85.
   PubMed Web of Science ®Google Scholar
• Kayser O, Olbrich C, Yardley V, Kiderlen AF, Croft SL. (2003). Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm, 254, 73–75.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Lehr CM. (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther, 299, 775–781.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 59, 631–644.
   PubMed Web of Science ®Google Scholar
• Kipp JE. (2004). The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm, 284, 109–122.
   PubMed Web of Science ®Google Scholar
• Kocbek P, Baumgartner S, Kristl J. (2006). Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm, 312, 179–186.
   PubMed Web of Science ®Google Scholar
• Kristl J, Dolenc A, Baumgartner S, Planinsek O. (2009). Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm, 376, 204–212.
   PubMedGoogle Scholar
• Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. (2009). Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int J Pharm, 373, 124–132.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther, 299, 775–781.
   PubMed Web of Science ®Google Scholar
• Latha S, Selvamani P, Kumar CS, Sharavanan P, Suganya G, Beniwal VS, Rao PR. (2009). Formulation development and evaluation of metronidazole magnetic nanosuspension as a magnetic-targeted and polymeric-controlled drug delivery system. J Mang Mang Mater, 321, 1580–1585.
   Web of Science ®Google Scholar
• Lee J, Cheng Y. (2006). Critical freezing rate in freeze drying nanocrystal dispersions. J Control Release, 111, 185–192.
   PubMed Web of Science ®Google Scholar
• Lee RW, Mcshane J, Shaw JM, Wood RW. (2000). Particle size reduction. In: Liu R, ed Water-Insoluble Drug Formation. Interpharm Press, Buffalo Grove, 455–492.
   Google Scholar
• Liversidge GG, Cundy KC, Bishop J, Czekai D. (1992). Surface modified drug nanoparticles. US Patent 5145684.
   Google Scholar
• Lou H, Zhang X, Gao L, Feng F, Wang J, Wei X, Yu Z, Zhang D, Zhang Q. (2009). In vitro and in vivo antitumor activity of oridonin nanosuspension. Int J Pharm, 379, 181–186.
   PubMed Web of Science ®Google Scholar
• Martien R, Loretz B, Sandbichler AM, Schnürch AB. (2008). Thiolated chitosan nanoparticles: transfection study in the Caco-2 differentiated cell culture. Nanotechnology, 19, 045101.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Müller RH, Keck CM. (2009). Development of an oral rutin nanocrystal formulation. Int J Pharm, 370, 202–209.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18, 113–120.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, McGurk SL, Liversidge GG. (2004). Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. Pharm Res, 21, 1545–1553.
   PubMed Web of Science ®Google Scholar
• Mishra PR, Al Shaal L, Müller RH, Keck CM. (2009). Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm, 371, 182–189.
   PubMed Web of Science ®Google Scholar
• Möschwitzer J, Achleitner G, Pomper H, Müller RH. (2004). Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm, 58, 615–619.
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Wan J, Xu H, Yang X. (2011). Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm, 413, 237–244.
   PubMed Web of Science ®Google Scholar
• Muller RH. (1996). Zeta potential und Partikelladung-Kurze Theorie, praktische Meßdurchfuhrung. Stuttgart: Dateninterpretation, Wissenschaftliche.
   Google Scholar
• Müller RH, Benita S, Böhm B. (1998). Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific, Stuttgart, 149–173.
   Google Scholar
• Muller RH, Becker R, Kruss B, Peters K. (1999). Pharmaceutical nanosuspensions for medicament administration as system of increased saturation solubility and rate of solution. US Patent 5858410.
   Google Scholar
• Müller RH, Jacobs C. (2002). Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm, 237, 151–161.
   PubMed Web of Science ®Google Scholar
• Müller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev, 47, 3–19.
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. (2004). Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol, 113, 151–170.
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Biopharm, 62, 3–16.
   PubMed Web of Science ®Google Scholar
• Muller RH, Peters K. (1998). Nanosuspensions for the formulation of poorly soluble drugs-I. Preparation by a size-reduction technique. Int J Pharm, 160, 229–237.
   Web of Science ®Google Scholar
• Nam YS, Kang HS, Park JY, Park TG, Han SH, Chang IS. (2003). New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials, 24, 2053–2059.
   PubMed Web of Science ®Google Scholar
• Ney P. (1974). Zetapotentiale und Flotierbarkeit von Mineralien. Wien: Springer.
   Google Scholar
• Patravale VB, Date AA, Kulkarni RM. (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol, 56, 827–840.
   PubMed Web of Science ®Google Scholar
• Ponchel G, Montisci MJ, Dembri A. (1997). Mucoadhesion of colloidal particulate systems in the gasrointesinal tract. Eur J Pharm Biopharm, 4, 25–31.
   Web of Science ®Google Scholar
• Rabinow BE. (2004). Nanosuspensions in drug delivery. Nat Rev Drug Discov, 3, 785–796.
   PubMed Web of Science ®Google Scholar
• Rabinow B, Kipp J, Papadopoulos P, Wong J, Glosson J, Gass J, Sun CS, Wielgos T, White R, Cook C, Barker K, Wood K. (2007). Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm, 339, 251–260.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. (2008). Nanotechnology in ocular drug delivery. Drug Discov Today, 13, 144–151.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88, 1058–1066.
   PubMed Web of Science ®Google Scholar
• Sun M, Gao Y, Pei Y, Guo C, Li H, Cao F, Yu A, Zhai G. (2010). Development of nanosuspension formulation for oral delivery of quercetin. J Biomed Nanotechnol, 6, 325–332.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. (2008). Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm, 354, 227–234.
   PubMed Web of Science ®Google Scholar
• Thassu D, Deleers M, Pathak Y. (2007). Nanoparticulate drug delivery systems. Informa Healthcare USA, Inc.
   Google Scholar
• Van den Mooter G, Van Eerdenbrugh B, Augustijns P. (2008a). Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364, 64–75.
   PubMedGoogle Scholar
• Van den Mooter G, Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P. (2008b). Drying of crystalline drug nanosuspensions—The importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur J Pharm Sci, 35, 127–135.
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. (2009a). A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm, 380, 216–222.
   PubMed Web of Science ®Google Scholar
• Verma S, Lan Y, Gokhale R, Burgess DJ. (2009b). Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm, 377, 185–198.
   PubMed Web of Science ®Google Scholar
• Wahlstrom JL, Chiang Po-Chang, Ghosh, S, Warren CJ, Wene SP, A., Albin LA, Smith ME, Roberds SL. (2007). Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment. Nanoscale Res Lett,2, 291–296.
   Web of Science ®Google Scholar
• Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. (2011a). Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm, 413, 194–201.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Z, Zhang D, Gao X, Zhang X, Duan C, Jia L, Feng F, Huang Y, Shen Y, Zhang Q. (2011b). Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension. Colloids Surf B Biointerfaces, 83, 189–197.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. (2010). In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology, 21, 155–104.
   Google Scholar
• Weibel DB, Whitesides GM. (2006). Applications of microfluidics in chemical biology. Curr Opin Chem Biol, 10, 584–591.
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci, 40, 325–334.
   PubMed Web of Science ®Google Scholar
• Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. (2008). Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm, 350, 338–343.
   PubMed Web of Science ®Google Scholar
• Yang W, Johnston KP, Williams RO 3rd. (2010). Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm, 75, 33–41.
   PubMed Web of Science ®Google Scholar
• Zhao YX, Hua HY, Chang M, Liu WJ, Zhao Y, Liu HM. (2010). Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions. Int J Pharm, 392, 64–71.
   PubMed Web of Science ®Google Scholar
• Zheng D, Wang Y, Zhang D, Liu Z, Duan C, Jia L, Wang F, Liu Y, Liu G, Hao L, Zhang Q. (2011). In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Cancer Lett, 307, 158–164.
   PubMed Web of Science ®Google Scholar